Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ProShares UltraShort Nasdaq Biotechnology (BIS)

During the Trading Day
30.86 -2.36 / -7.10%
As of 4:14pm ET
Day’s Change
During After-Hours   Switch to standard view »
30.75 -0.11 / -0.36%
 
Volume: 2.0K

Investment Objective

The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index . The fund invests in derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times the inverse (-2x) of the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. It is non-diversified.

No recent news for ProShares UltraShort Nasdaq Biotechnology.

Performance

1 month+26.63% 3 years-54.42%
3 months+12.03% 5 years-52.76%
1 year-44.12% Since inception-48.47%
Data through 09/02/2015

Quote Details

Previous close$33.22
Open day’s range30.77 – 33.25
Net asset value (NAV)33.33 (09/01/2015)
Daily volume658,023
Average volume (3 months)703,989
Data as of 4:14pm ET, 09/02/2015

Peer Comparisonvs. Trading-inverse equity ETFs

 BISCategory
Performance 5-yr return-52.76%-30.54%
Expense Gross exp ratio1.45%0.94%
Risk 5 year sharpe ratio-2.32--
Net assets$115.4M$114.8M
Average market cap----
Average P/E----
Dividend / Share--0.35%

Competitors

SDS ProShares UltraShort S&P500
SH ProShares Short S&P500
TOTS Direxion Daily Total Market Bear 1X Shar...

Holdings

Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
Holdings not available.

Partner Offers